Try our beta test site

Efficacy and Safety of Tenofovir DF/Atazanavir Enhanced With Low Dose of Ritonavir in HIV-Infected Patients

This study has been terminated.
Bristol-Myers Squibb
Gilead Sciences
Information provided by:
French National Agency for Research on AIDS and Viral Hepatitis Identifier:
First received: July 19, 2005
Last updated: July 27, 2005
Last verified: July 2005